Sign In
Buy ACHV
$4.92
-0.110 (-2.19%)
At Close: Jun 03, 2026
Achieve Life Sciences Announces Participation at Upcoming Investor Conferences
04:30pm, Monday, 11'th Dec 2023
SEATTLE and VANCOUVER, British Columbia, Dec. 11, 2023 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage pharmaceutical company committed to the global development and comme
Achieve Life Sciences, Inc. (ACHV) Q3 2023 Earnings Call Transcript
08:08pm, Thursday, 09'th Nov 2023
Achieve Life Sciences, Inc. (NASDAQ:ACHV ) Q3 2023 Earnings Conference Call November 9, 2023 4:30 PM ET Company Participants Nicole Jones - IR John Bencich - CEO Jerry Wan - Principal Accounting Offic
Achieve Life Sciences to Announce Third Quarter 2023 Financial Results and Host Conference Call and Webcast on November 9, 2023
08:00am, Thursday, 26'th Oct 2023
SEATTLE and VANCOUVER, British Columbia, Oct. 26, 2023 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (NASDAQ: ACHV), a late-stage clinical pharmaceutical company committed to the global development
Achieve Life Sciences Announces Participation at Upcoming Investor Conferences
08:00am, Tuesday, 03'rd Oct 2023
SEATTLE and VANCOUVER, British Columbia, Oct. 03, 2023 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage pharmaceutical company committed to the global development and comme
SEATTLE and VANCOUVER, British Columbia, Sept. 11, 2023 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (NASDAQ: ACHV), a late-stage clinical pharmaceutical company committed to the global development
Achieve Life Sciences, Inc. (ACHV) Q2 2023 Earnings Call Transcript
10:01am, Tuesday, 15'th Aug 2023
Achieve Life Sciences, Inc. (NASDAQ:ACHV ) Q2 2023 Earnings Conference Call August 15, 2023 8:30 AM ET Company Participants Nicole Jones - Investor Relations John Bencich - Chief Executive Officer Jer
Achieve Life Sciences Reports Financial Results for Second Quarter 2023 and Provides Corporate Update
04:00pm, Monday, 14'th Aug 2023
Company to host conference call tomorrow, Tuesday, August 15, 2023, at 8:30 AM EDT SEATTLE and VANCOUVER, British Columbia, Aug. 14, 2023 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (NASDAQ: ACHV)
Achieve Life Sciences to Announce Second Quarter 2023 Financial Results and Host Conference Call and Webcast
08:00am, Tuesday, 01'st Aug 2023
SEATTLE and VANCOUVER, British Columbia, Aug. 01, 2023 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (NASDAQ: ACHV), a late-stage clinical pharmaceutical company committed to the global development
Achieve: Exciting Smoking Cessation Drug Approval Could Come Soon
04:39am, Sunday, 28'th May 2023
Efficacy: Phase 3 ORCA-3 trial showed significant efficacy of cytisinicline in smoking cessation, reinforcing data from ORCA-2. Safety: Cytisinicline exhibited no serious treatment-related adverse eve
Achieve Life Sciences says confirmatory late-stage trial of its treatment for quitting smoking achieved positive results
06:12am, Tuesday, 23'rd May 2023
Achieve Life Sciences Inc. ACHV, +12.88% said Tuesday a second confirmatory late-stage trial of its cytisinicline for quitting smoking and nicotine dependence achieved positive results, showing a stat
Achieve Life Sciences to Announce First Quarter 2023 Financial Results and Host Conference Call and Webcast on May 9, 2023
08:00am, Wednesday, 26'th Apr 2023
SEATTLE and VANCOUVER, British Columbia, April 26, 2023 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (NASDAQ: ACHV), a late-stage clinical pharmaceutical company committed to the global development
Achieve: Late-Stage Biotech Developing Vaping And Smoking Cessation Drugs
04:37pm, Tuesday, 25'th Apr 2023
Achieve: Late-Stage Biotech Developing Vaping And Smoking Cessation Drugs.
Achieve Life Sciences to Present at Life Science Innovation Northwest 2023 Conference
08:00am, Friday, 14'th Apr 2023
SEATTLE and VANCOUVER, British Columbia, April 14, 2023 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage pharmaceutical company committed to the global development and comm
Achieve Life Sciences, Inc. (ACHV) Q4 2022 Earnings Call Transcript
09:33pm, Thursday, 16'th Mar 2023
Achieve Life Sciences, Inc. (NASDAQ:ACHV ) Q4 2022 Earnings Conference Call March 16, 2023 4:30 PM ET Company Participants Nicole Jones - Investor Relations John Bencich - Chief Executive Officer Cind
Achieve Life Sciences: All Eyes On Phase 3 Data For Smoking Cessation Drug
11:45pm, Saturday, 28'th Jan 2023
ORCA-2 phase 3 trial was a success where Cytisinicline has shown statistically significant improvement in quit rates and robust safety profile. Phase 3 ORCA-3 registration trial is ongoing, and we exp
